These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10852114)

  • 21. Natural antibodies and the autoimmunity of atherosclerosis.
    Binder CJ; Silverman GJ
    Springer Semin Immunopathol; 2005 Mar; 26(4):385-404. PubMed ID: 15609021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses.
    Buono C; Binder CJ; Stavrakis G; Witztum JL; Glimcher LH; Lichtman AH
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1596-601. PubMed ID: 15665085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of T lymphocytes in the pathogenesis of atherosclerosis: animal studies using athymic nude rats.
    Haraoka S; Shimokama T; Watanabe T
    Ann N Y Acad Sci; 1997 Apr; 811():515-8. PubMed ID: 9186630
    [No Abstract]   [Full Text] [Related]  

  • 24. Innate IFN-gamma production by subsets of natural killer cells, natural killer T cells and gammadelta T cells in response to dying bacterial-infected macrophages.
    Kubota K
    Scand J Immunol; 2010 Mar; 71(3):199-209. PubMed ID: 20415785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions.
    Aslanian AM; Chapman HA; Charo IF
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):628-32. PubMed ID: 15591216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation.
    Cuff CA; Kothapalli D; Azonobi I; Chun S; Zhang Y; Belkin R; Yeh C; Secreto A; Assoian RK; Rader DJ; Puré E
    J Clin Invest; 2001 Oct; 108(7):1031-40. PubMed ID: 11581304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
    Daugherty A; Puré E; Delfel-Butteiger D; Chen S; Leferovich J; Roselaar SE; Rader DJ
    J Clin Invest; 1997 Sep; 100(6):1575-80. PubMed ID: 9294126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocytes in atherosclerosis.
    Hedrick CC
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):253-7. PubMed ID: 25609772
    [No Abstract]   [Full Text] [Related]  

  • 29. [Association of ocular inflammation and innate immune response].
    Sonoda KH
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):279-97; discussion 298. PubMed ID: 18411715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of adaptive immunity by natural killer cells.
    Kos FJ
    Immunol Res; 1998; 17(3):303-12. PubMed ID: 9638474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of atherosclerosis in mice by inhibition of CD40 signalling.
    Mach F; Schönbeck U; Sukhova GK; Atkinson E; Libby P
    Nature; 1998 Jul; 394(6689):200-3. PubMed ID: 9671306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunity, inflammation and atherosclerosis].
    Capron L
    Rev Neurol (Paris); 1993; 149(12):751-4. PubMed ID: 7997733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.
    Shaw PX
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):225-39. PubMed ID: 15467487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anichkov's views on the role of macrophages in atherogenesis and evolution of such views up to now].
    Nagornev VA; Mal'tseva SV; Vaskan'iants AN
    Arkh Patol; 2003; 65(2):8-12. PubMed ID: 15357240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NK and NKT cell functions in immunosenescence.
    Mocchegiani E; Malavolta M
    Aging Cell; 2004 Aug; 3(4):177-84. PubMed ID: 15268751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall.
    Ketelhuth DF; Hansson GK
    Thromb Haemost; 2011 Nov; 106(5):779-86. PubMed ID: 21979058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory T-cell immunity and its relevance to atherosclerosis.
    Taleb S; Tedgui A; Mallat Z
    J Intern Med; 2008 May; 263(5):489-99. PubMed ID: 18410592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-stimulation and plaque-antigen-specific T-cell responses in atherosclerosis.
    Buono C; Lichtman AH
    Trends Cardiovasc Med; 2004 May; 14(4):166-72. PubMed ID: 15177268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.